Back to Search
RAYMOND ANTON, MD
MD
Addiction Psychiatry Physician
NPI: 1932304896Individual
Specialties, Licenses & Credentials
Addiction Psychiatry PhysicianPrimary
Psychiatry & Neurology — Addiction Psychiatry
Code: 2084P0802X
10069(SC)
Clinical Trials (3)
3
Linked Trials
0
Recruiting
2
With Results
Genetic and Brain Mechanisms of Naltrexone's Treatment Efficacy for Alcoholism
NCT00920829COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Effectiveness of Naltrexone Versus Placebo to Reduce Craving for Alcohol With Evaluation of Genetic Variability.
NCT00366626COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Behavioral Therapy Plus Naltrexone for Alcoholism
NCT00000456COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
PMID 28409564·Neuropsychopharmacology·2017
2-rct
Naltrexone modification of drinking effects in a subacute treatment and bar-lab paradigm: influence of OPRM1 and dopamine transporter (SLC6A3) genes.
PMID 22551036·Alcohol Clin Exp Res·2012
2-rct
Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
PMID 16012278·J Clin Psychopharmacol·2005
3-trial
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms.
PMID 19593171·J Clin Psychopharmacol·2009
2-rct
A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
PMID 18204334·J Clin Psychopharmacol·2008
4-observational
An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study.
PMID 18250251·Arch Gen Psychiatry·2008
4-observational
Factors affecting %CDT status at entry into a multisite clinical treatment trial: experience from the COMBINE Study.
PMID 17067352·Alcohol Clin Exp Res·2006
2-rct
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.
PMID 16670409·JAMA·2006
4-observational
Measurement and choice of drinking outcome variables in the COMBINE Study.
PMID 16223062·J Stud Alcohol Suppl·2005
8-other
A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence.
PMID 15232334·J Clin Psychopharmacol·2004
3-trial
Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking.
PMID 14722705·Psychopharmacology (Berl)·2004
3-trial
Carbohydrate-deficient transferrin and gamma-glutamyltransferase for the detection and monitoring of alcohol use: results from a multisite study.
PMID 12198396·Alcohol Clin Exp Res·2002
4-observational
Carbohydrate-deficient transferrin for detection and monitoring of sustained heavy drinking. What have we learned? Where do we go from here?
PMID 11839464·Alcohol·2001
6-review
Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism.
PMID 11199951·J Clin Psychopharmacol·2001
3-trial
Comparison of Bio-Rad %CDT TIA and CDTect as laboratory markers of heavy alcohol use and their relationships with gamma-glutamyltransferase.
PMID 11568085·Clin Chem·2001
3-trial
Pharmacologic approaches to the management of alcoholism.
PMID 11584870·J Clin Psychiatry·2001
6-review
Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale.
PMID 11002915·Addiction·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 67 PRESIDENT ST # 4NORTH
CHARLESTON, SC 29425 - Phone
- (843) 722-6309
Quick Facts
- NPI
- 1932304896
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile